Banco BTG Pactual S.A. Has $376,000 Stock Holdings in Danaher Corporation $DHR

Key Points

• Banco BTG Pactual S.A. has reduced its stake in Danaher Corporation by 45.3%, now holding 1,836 shares valued at approximately $376,000.
• Danaher reported $1.80 EPS for its latest quarter, surpassing analysts' expectations of $1.64, with a revenue of $5.94 billion.
• Analysts have given Danaher an average rating of "Moderate Buy" with a target price of $247.61, indicating positive sentiment among market experts.

Banco BTG Pactual S.A. lowered its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 45.3% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,836 shares of the conglomerate's stock after selling 1,518 shares during the period. Banco BTG Pactual S.A.'s holdings in Danaher were worth $376,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of DHR. Bank Pictet & Cie Europe AG raised its stake in Danaher by 22.8% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 192,731 shares of the conglomerate's stock worth $44,241,000 after buying an additional 35,730 shares during the period. XTX Topco Ltd bought a new position in shares of Danaher in the fourth quarter worth $420,000. First Trust Advisors LP boosted its holdings in shares of Danaher by 13.6% in the fourth quarter. First Trust Advisors LP now owns 37,854 shares of the conglomerate's stock worth $8,689,000 after acquiring an additional 4,519 shares during the period. MML Investors Services LLC raised its position in shares of Danaher by 2.2% in the fourth quarter. MML Investors Services LLC now owns 91,504 shares of the conglomerate's stock worth $21,005,000 after buying an additional 1,984 shares in the last quarter. Finally, Transce3nd LLC purchased a new stake in Danaher during the fourth quarter valued at about $49,000. Institutional investors own 79.05% of the company's stock.

Danaher Trading Up 1.5%

DHR opened at $212.2350 on Wednesday. The stock has a market capitalization of $151.97 billion, a PE ratio of 45.16, a P/E/G ratio of 2.92 and a beta of 0.73. The business's 50 day moving average price is $200.33 and its 200 day moving average price is $199.54. Danaher Corporation has a one year low of $171.00 and a one year high of $279.90. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. The business had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business's revenue was up 3.4% compared to the same quarter last year. During the same period in the previous year, the business posted $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities research analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have weighed in on DHR. Barclays reaffirmed an "overweight" rating and set a $225.00 price objective (up from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. UBS Group lowered their price target on Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a report on Wednesday, July 23rd. The Goldman Sachs Group reduced their price objective on Danaher from $260.00 to $240.00 and set a "neutral" rating for the company in a research note on Wednesday, April 23rd. JPMorgan Chase & Co. dropped their target price on shares of Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a report on Tuesday, April 22nd. Finally, Evercore ISI dropped their target price on shares of Danaher from $230.00 to $226.00 and set an "outperform" rating for the company in a report on Tuesday, July 8th. Seventeen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Danaher currently has an average rating of "Moderate Buy" and an average price target of $247.61.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.